UNSPSC 85323502: Diagnosis of sarcoidosis of lymph nodes

This classification denotes the group of activities that yields a diagnosis of Sarcoidosis of lymph nodes. Sarcoidosis of lymph nodes is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code D86. 1

UNSPSC 85323502 Diagnosis of sarcoidosis of lymph nodes is a Commodity code with minimal direct alignment to recent state and local procurement activity. The code's nominal scope—clinical diagnostic procedures for a specific lymphatic condition—does not correspond to the work actually being solicited under this classification in available records. Recent opportunities posted under this code span diagnostic imaging systems infrastructure, special education contracted services, and temporary health professional staffing—none of which involve sarcoidosis diagnosis as a primary deliverable or service line. The mismatch suggests either a taxonomy classification error in the source records or exceptionally sparse relevant activity under this code's true scope.

No recent state and local opportunities directly procure sarcoidosis diagnostic services or related clinical protocols under this code. The three posted solicitations—San Mateo Medical Center's Diagnostic Imaging PACS system (RFP, due October 21, 2026), Birdville Independent School District's special education contracted services (competitive sealed proposals, due October 21, 2026), and Santa Clara County Health System's temporary health professional staffing pool (RFQ, closed October 7, 2026)—address infrastructure modernization, educational support, and clinical staffing, respectively, rather than diagnostic procedures for lymph node conditions. The geographic spread of available records covers California (San Mateo and Santa Clara counties) and Texas (Tarrant County), but these jurisdictions show no procurement activity specific to the code's stated scope. For vendors pursuing genuine opportunities under this Commodity code, the classification signal appears unreliable; verification of actual buying patterns and direct outreach to issuing bodies' clinical procurement teams is warranted.